The premise behind the widespread use of androgenic steroids by athletes that these agents enhance protein synthesis and muscle strength is not supported by data. In this regard, the objectives of the proposed studies are to examine whether superphysiological doses of androgenic steroids promote nitrogen retention, protein synthesis and skeletal muscle performance in eugonadal men. It s hypothesized that androgenic steroids promote nitrogen retention and protein synthesis only in hypogonadal men, and that superphysiological doses of androgenic steroids do not further increase nitrogen retention, protein synthesis or muscle strength when confounding variables such as exercise training stimulus and dietary intake are controlled. Four groups of ten healthy, eugonadal men will be treated as follows: Group 1: vehicle, no exercise; Group 2: vehicle, exercise training, Group 3: testosterone enanthate (TE) 600 mg 1M every week, no exercise. Group 4: TE (600 mg/wk) plus exercise training. The following will be studied before and after 10 weeks of treatment: cross-sectional areas of the muscle and subcutaneous tissue of the arm and the thigh by MR scanning; modified nitrogen balance assessed by urinary and fecal nitrogen measurements during a defined nitrogen intake; whole body L-[1-13C] leucine turnover and oxidation; fractional muscle protein synthesis; body composition analysis by H2 18O dilution and hydrostatic weighing; maximal muscle strength by 1RM of a defined weight lifting exercise, and submaximal muscle performance by analysis of integrated EMG: force relationships. In addition total and free testosterone (T), dihydrotestosterone, LH, FSH and SHBG levels will be monitored before, during and after treatment as markers of androgen bioavailability and action. Confounding variables such as age, caloric and protein intake, and the level of exercise training stimulus will be strictly controlled. In addition, ten hypogonadal men will undergo the following studies before and after 10 weeks of TE (100 mg/wk) primarily to demonstrate that replacement doses of androgenic steroids promote nitrogen retention and protein synthesis in hypogonadal men; modified nitrogen balance, whole body L-[1-13C] leucine turnover and oxidation; fractional muscle protein synthesis; cross-sectional areas of the muscle and subcutaneous tissue by MR scanning; body composition analysis by H2 18O dilution, and hydrostatic weighing; and total and free T, dihydrotestosterone LH, FSH and SHBG. These studies should help dispel some of the myths surrounding the use of androgenic steroids.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK045211-04
Application #
2144409
Study Section
Endocrinology Study Section (END)
Project Start
1992-05-01
Project End
1996-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Arver, S; Sinha-Hikim, I; Beall, G et al. (1999) Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss. J Androl 20:611-8
Sinha-Hikim, I; Arver, S; Beall, G et al. (1998) The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 83:1312-8
Bhasin, S; Bremner, W J (1997) Clinical review 85: Emerging issues in androgen replacement therapy. J Clin Endocrinol Metab 82:3-8
Bhasin, S; Storer, T W; Berman, N et al. (1997) Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82:407-13
Kastury, K; Taylor, W E; Gutierrez, M et al. (1997) Chromosomal mapping of two members of the human dynein gene family to chromosome regions 7p15 and 11q13 near the deafness loci DFNA 5 and DFNA 11. Genomics 44:362-4
Kastury, K; Taylor, W E; Shen, R et al. (1997) Complementary deoxyribonucleic acid cloning and characterization of a putative human axonemal dynein light chain gene. J Clin Endocrinol Metab 82:3047-53
Tricker, R; Casaburi, R; Storer, T W et al. (1996) The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men--a clinical research center study. J Clin Endocrinol Metab 81:3754-8
Najmabadi, H; Huang, V; Yen, P et al. (1996) Substantial prevalence of microdeletions of the Y-chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy. J Clin Endocrinol Metab 81:1347-52
Bhasin, S; Storer, T W; Berman, N et al. (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335:1-7
Najmabadi, H; Chai, N; Kapali, A et al. (1996) Genomic structure of a Y-specific ribonucleic acid binding motif-containing gene: a putative candidate for a subset of male infertility. J Clin Endocrinol Metab 81:2159-64